Liau LM - Search Results

1

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma.

Lee AH, Sun L, Mochizuki AY, Reynoso JG, Orpilla J, Chow F, Kienzler JC, Everson RG, Nathanson DA, Bensinger SJ, Liau LM, Cloughesy T, Hugo W, Prins RM. Lee AH, et al. Among authors: liau lm. Nat Commun. 2021 Nov 26;12(1):6938. doi: 10.1038/s41467-021-26940-2. Nat Commun. 2021. PMID: 34836966 Free PMC article.

2

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.

Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Liau LM, et al. J Neurosurg. 1999 Jun;90(6):1115-24. doi: 10.3171/jns.1999.90.6.1115. J Neurosurg. 1999. PMID: 10350260

3

Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS. Choe G, et al. Among authors: liau lm. Clin Cancer Res. 2002 Sep;8(9):2894-901. Clin Cancer Res. 2002. PMID: 12231534

4

Identification of molecular subtypes of glioblastoma by gene expression profiling.

Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF. Mischel PS, et al. Among authors: liau lm. Oncogene. 2003 Apr 17;22(15):2361-73. doi: 10.1038/sj.onc.1206344. Oncogene. 2003. PMID: 12700671

5

Immunology and immunotherapy in neurosurgical disease.

Prins RM, Liau LM. Prins RM, et al. Among authors: liau lm. Neurosurgery. 2003 Jul;53(1):144-52; discussion 152-3. doi: 10.1227/01.neu.0000068865.34216.3a. Neurosurgery. 2003. PMID: 12823883 Review.

6

Gene expression profiling identifies molecular subtypes of gliomas.

Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Shai R, et al. Among authors: liau lm. Oncogene. 2003 Jul 31;22(31):4918-23. doi: 10.1038/sj.onc.1206753. Oncogene. 2003. PMID: 12894235

7

Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.

Prins RM, Odesa SK, Liau LM. Prins RM, et al. Among authors: liau lm. Cancer Res. 2003 Dec 1;63(23):8487-91. Cancer Res. 2003. PMID: 14679014

8

p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition.

Wang Y, Zhu S, Cloughesy TF, Liau LM, Mischel PS. Wang Y, et al. Among authors: liau lm. Oncogene. 2004 Feb 12;23(6):1283-90. doi: 10.1038/sj.onc.1207244. Oncogene. 2004. PMID: 14961077

9

Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme.

Yang I, Kremen TJ, Giovannone AJ, Paik E, Odesa SK, Prins RM, Liau LM. Yang I, et al. Among authors: liau lm. J Neurosurg. 2004 Feb;100(2):310-9. doi: 10.3171/jns.2004.100.2.0310. J Neurosurg. 2004. PMID: 15086239

10

Cellular immunity and immunotherapy of brain tumors.

Prins RM, Liau LM. Prins RM, et al. Among authors: liau lm. Front Biosci. 2004 Sep 1;9:3124-36. doi: 10.2741/1465. Front Biosci. 2004. PMID: 15353342 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page